Asthma

The use of an inhaled corticosteroid, long-acting beta 2 agonist and long-acting muscarinic antagonist improved asthma outcomes compared with use of just two of those medications, according to a study published in Respiratory Medicine.

WASHINGTON — The use of single-inhaler and multiple-inhaler therapies for asthma control as needed offers a variety of pros and cons, according to a presentation at the American Thoracic Society International Conference.

Adherence with asthma medication was lower when recorded by a mobile app compared with patient-reported and physician-reported results, according to a study published in Clinical and Translational Allergy.

In this video interview, Kaharu Sumino, MD, MPH, discusses a presentation on asthma reliever options for pediatric patients from the American Thoracic Society International Conference.

In this video, Kaharu Sumino, MD, MPH, discusses a presentation on the use of inhaled corticosteroids plus formoterol as a reliever therapy in patients with asthma from the American Thoracic Society International Conference.

Healio spoke with Kaharu Sumino, MD, MPH, about a symposium presentation on asthma relievers from the American Thoracic Society International Conference.

Healio spoke with Kaharu Sumino, MD, MPH, about a presentation from this year’s American Thoracic Society International Conference on global issues in asthma care.

The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer-issued press release.

WASHINGTON — Male and female patients experienced similar improvements in their severe, uncontrolled asthma with tezepelumab over a 52-week period, according to data presented at the American Thoracic Society International Conference.

The Institute for Exposomic Research at Mount Sinai has received a 5-year grant totaling $8.45 million from the NIH to support research studying how the environment impacts health across the lifespan.